Delivery Order SPE2DB20D1100-SPE2DB25FY49F

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of WEGOVY 1.7 mg/0.75 ml pens. The contract has a ceiling value of $2,194.16 and a completion date of May 16, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $14,924.26 and runs through October 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1.7 mg/0.75 ml pens. The contract has a Firm Fixed Price pricing type and a ceiling value of $18,376.06. The ultimate completion date is April 2, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.5 mg/0.5 ml pens. The contract is a firm fixed-price agreement with a ceiling value of $7,707.62 and a period of performance through February 27, 2025. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a total ceiling value of $3,835.32 and a period of performance through February 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $14,094.53 and a period of performance through July 5, 2024. It is a firm fixed-price, delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1.7 mg/0.75 ml pens. The contract has a ceiling value of $6,822.94 and a period of performance through July 19, 2024. It is a firm-fixed-price contract, with no set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,401.89 and an ultimate completion date of March 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medication, with a ceiling value of $2,603.37. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $11,691.56 and a period of performance ending on April 9, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FY49F
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 mg/0.5 ml pens. The contract has a ceiling value of $15,832.80 and a period of performance through October 11, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation.

Generated 1/9/25, 9:27 AM